(Q83392905)
Statements
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration (English)
Michael A Singer
Carl C Awh
SriniVas Sadda
William R Freeman
Andrew N Antoszyk
Pamela Wong